[Several important issues in the antiviral therapy of hepatitis B].
Yu
Yue-cheng
YC
Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Nanfang Medical University, Guangzhou, 510515, China.
Hou
Jin-lin
JL
D000998:Antiviral Agents / Q000627:therapeutic use*; D005500:Follow-Up Studies; D019694:Hepatitis B, Chronic / Q000628:therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D019259:Lamivudine / Q000627:therapeutic use*; D011994:Recombinant Proteins; D055502:Secondary Prevention
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D019259:Lamivudine